Valsartan, an angiotensin II receptor blocker, attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity

Cardiovascular Toxicology

Volumn 11, Issue 2, 2011, Pages 148-156

  Goyal, Sameer ^a   Bharti, Saurabh ^a   Sahoo, Kanhei Charan ^a   Sharma, Ashok Kumar ^a   Arya, Dharamvir Singh ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Angiotensin receptor blocker; Cardiotoxicity; Isoproterenol; Oxidative stress; Valsartan

Indexed keywords

CREATINE KINASE; LACTATE DEHYDROGENASE; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; ENZYME ACTIVITY; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART PROTECTION; HISTOPATHOLOGY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CARDIOTOXINS; HEART DISEASES; HEART RATE; ISOPROTERENOL; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; TETRAZOLES; VALINE;

RATTUS;

EID: 79958046630     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-011-9108-0     Document Type: Article

References (25)

1. MA Pfeffer 2000 Will more complete inhibition of the RAAS with angiotensin receptor blockade improve survival following myocardial infarction? Journal of the Renin-Angiotensin-Aldosterone System 1 S41 S43 17199221 10.3317/jraas.2000.056 1:STN:280:DC%2BD2s%2FgtlWrtw%3D%3D
2. AD Lopez CC Murrau 1998 The global burden disease, 1990-2020 Nature Medicine 4 1241 1243 9809543 10.1038/3218 1:CAS:528:DyaK1cXntlantbk%3D (Pubitemid 28512100)
3. XZ Guo K Shoji N Akira S Takatomi R Matlubur Y Li N Yukiko F Yoshihide M Akira A Youichi 2005 Cardiac oxidative stress in acute and chronic isoproterenol-infused rats Cardiovascular Research 65 230 238 10.1016/j.cardiores.2004.08.013 (Pubitemid 40038496)
4. Heart and Stroke facts 2002. (2003). Statistical supplement. Dallas: American Heart Association.
5. M Böhm M Baumhäkel F Mahfoud C Werner 2010 From evidence to rationale: Cardiovascular protection by angiotensin II receptor blockers compared with angiotensin-converting enzyme inhibitors Cardiology 117 163 173 21051889 10.1159/000320094
6. J Milei RG Nunez M Rapaport 1978 Pathogenesis of isoprenaline-induced myocardial lesions: Its relation to human 'coagulative myocytolysis' Cardiology 63 139 151 639073 10.1159/000169891 1:CAS:528:DyaE1cXksFensrw%3D (Pubitemid 8294128)
7. P Verdecchia F Angeli S Repaci G Mazzotta G Gentile G Reboldi 2009 Comparative assessment of angiotensin receptor blockers in different clinical settings Vascular Health and Risk Management 5 939 948 19997575 10.2147/VHRM.S7263 1:CAS:528:DC%2BD1MXhsVKlt7nI
8. HR Black J Bailey D Zappe R Samuel 2009 Valsartan: More than a decade of experience Drugs 69 2393 2414 19911855 10.2165/11319460-000000000-00000 1:CAS:528:DC%2BC3cXhtVSltb8%3D
9. JN Cohn G Tognoni 2001 Valsartan heart failure trial investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure New England Journal of Medicine 345 1667 1675 11759645 10.1056/NEJMoa010713 1:CAS:528:DC%2BD3MXovFKjtLc%3D (Pubitemid 33126822)
10. JJ McMurray RR Holman S Haffner The NAVIGATOR Study Group, et al. 2010 Effect of valsartan on the incidence of diabetes and cardiovascular events New England Journal of Medicine 362 1477 1490 20228403 10.1056/NEJMcp0909392 1:CAS:528:DC%2BC3cXlt12rsbo%3D
11. N Tominaga A Robert Y Izuhara S Ohtomo T Dan K Chihara K Kurokawa Van Ypersele C de Strihou T Miyata 2009 Very high doses of valsartan provide renoprotection independently of blood pressure in a type 2 diabetic nephropathy rat model Nephrology (Carlton) 14 581 587 10.1111/j.1440-1797.2009.01143.x 1:CAS:528:DC%2BD1MXht1KitLvP
12. T Wang KS Yin KY Liu GJ Lu YH Li JD Chen 2008 Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats Chinese Medical Journal (England) 121 2312 2319 1:CAS:528: DC%2BD1MXps1ersQ%3D%3D
13. S Goyal S Arora R Mittal S Joshi TC Nag R Ray S Kumari DS Arya 2009 Myocardial salvaging effect of telmisartan in experimental model of myocardial infarction European Journal of Pharmacology 619 75 84 19664617 10.1016/j.ejphar.2009.07.026 1:CAS:528:DC%2BD1MXhtFajsLjI
14. H Ohkawa N Ohishi K Yagi 1979 Assay of lipid peroxide in animal tissue by thiobarbituric acid reaction Analytical Biochemistry 95 351 358 36810 10.1016/0003-2697(79)90738-3 1:CAS:528:DyaE1MXksFaisbk%3D (Pubitemid 9194347)
15. MS Moron JW Depierre B Manmerik 1979 Level of glutathione, glutathione reductase and glutathione S transferase activity in rat lung and liver Biochimica et Biophysica Acta 582 67 78 760819 1:CAS:528:DyaE1MXhtVSkurw%3D (Pubitemid 9065588)
16. Aebi, H. (1974). Catalase. In H. U. Bergmeyer (Ed.), Methods of enzymatic analysis (pp. 673-685). London: Academic Press.
17. S Marklund G Marklund 1974 Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase European Journal of Biochemistry 47 469 474 4215654 10.1111/j.1432-1033.1974. tb03714.x 1:CAS:528:DyaE2MXhtlGm
18. MM Bradford 1976 A rapid and sensitive method for quantization of microgram quantities of protein utilizing the principle of protein-dye binding Analytical Biochemistry 72 248 254 942051 10.1016/0003-2697(76)90527-3 1:CAS:528:DyaE28XksVehtrY%3D
19. F Albayrak Y Bayir Z Halici E Kabalar E Bayram C Ozturk H Suleyman MS Keles M Kurt E Bakan 2009 Preventive effect of amiodarone during acute period in isoproterenol-induced myocardial injury in Wistar rats Cardiovascular Toxicology 9 161 168 19714493 10.1007/s12012-009-9049-z 1:CAS:528: DC%2BD1MXhsVajt7rN
20. GX Zhang K Ohmori Y Nagai Y Fujisawa A Nishiyama Y Abe S Kimura 2007 Role of AT1 receptor in isoproterenol-induced cardiac hypertrophy and oxidative stress in mice Journal of Molecular and Cellular Cardiology 42 804 811 17350036 10.1016/j.yjmcc.2007.01.012 1:CAS:528:DC%2BD2sXjvFemsr4%3D (Pubitemid 46527601)
21. A Jalowy R Schulz G Heusch 1999 AT1 receptor blockade in experimental myocardial ischemia/reperfusion Journal of the American Society of Nephrology, Suppl 11 S129 S136
22. T Ohta N Hasebe S Tsuji K Izawa YT Jin S Kido S Natori M Sato K Kikuchi 2004 Unequal effects of renin-angiotensin system inhibitors in acute cardiac dysfunction induced by isoproterenol American Journal of Physiology. Heart and Circulatory Physiology 287 H2914 H2921 15297251 10.1152/ajpheart.00221.2004 1:CAS:528:DC%2BD2cXhtVOmu7%2FI (Pubitemid 39561727)
23. MS Keles Y Bayir H Suleyman Z Halici 2009 Investigation of effects of Lacidipine, Ramipril and Valsartan on DNA damage and oxidative stress occurred in acute and chronic periods following isoproterenol-induced myocardial infarct in rats Molecular and Cellular Biochemistry 328 109 117 19296206 10.1007/s11010-009-0080-y 1:CAS:528:DC%2BD1MXnvFKgsLk%3D
24. M Kato T Sada M Mizuno K Kitayama T Inaba H Koike 2005 Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits Journal of Cardiovascular Pharmacology 46 556 562 16160612 10.1097/01.fjc.0000179434.18750. 28 1:CAS:528:DC%2BD2MXpvFOrsro%3D (Pubitemid 41407587)
25. AC Akinmoladun EM Obuotor MK Barthwal M Dikshit EO Farombi 2010 Ramipril-like activity of Spondias mombin linn against no-flow ischemia and isoproterenol-induced cardiotoxicity in rat heart Cardiovascular Toxicology 10 295 305 20872093 10.1007/s12012-010-9089-4 1:CAS:528:DC%2BC3cXhsVCmsb7F